首页 > 最新文献

Integrated Blood Pressure Control最新文献

英文 中文
Pulmonary Hypertension in Pregnancy: Challenges and Solutions 妊娠期肺动脉高压:挑战和解决方案
IF 2.2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-04-01 DOI: 10.2147/IBPC.S242242
H. Afify, A. Kong, Jopher Bernal, I. Elgendy
Abstract Pulmonary hypertension (PH) is a heterogeneous disease characterized by an elevated mean pulmonary artery pressure of 20 mm Hg or above. PH is a prevalent condition among women of reproductive age and is linked with poor prognosis during pregnancy. Pregnancy is a stressful event and complicates the management and prognosis in patients with PH. In this review, we discuss the pathogenesis, clinical presentation as well as therapeutic options for PH during pregnancy. We also highlight knowledge gaps to guide future research.
摘要肺动脉高压(PH)是一种异质性疾病,其特征是平均肺动脉压升高20毫米汞柱或以上。PH是育龄妇女的常见疾病,与妊娠期预后不良有关。妊娠是一种压力事件,使PH患者的治疗和预后复杂化。在这篇综述中,我们讨论了妊娠期PH的发病机制、临床表现以及治疗选择。我们还强调了知识差距,以指导未来的研究。
{"title":"Pulmonary Hypertension in Pregnancy: Challenges and Solutions","authors":"H. Afify, A. Kong, Jopher Bernal, I. Elgendy","doi":"10.2147/IBPC.S242242","DOIUrl":"https://doi.org/10.2147/IBPC.S242242","url":null,"abstract":"Abstract Pulmonary hypertension (PH) is a heterogeneous disease characterized by an elevated mean pulmonary artery pressure of 20 mm Hg or above. PH is a prevalent condition among women of reproductive age and is linked with poor prognosis during pregnancy. Pregnancy is a stressful event and complicates the management and prognosis in patients with PH. In this review, we discuss the pathogenesis, clinical presentation as well as therapeutic options for PH during pregnancy. We also highlight knowledge gaps to guide future research.","PeriodicalId":45299,"journal":{"name":"Integrated Blood Pressure Control","volume":"15 1","pages":"33 - 41"},"PeriodicalIF":2.2,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46428192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Serum Levels of NT-Pro BNP in Patients with Preeclampsia 子痫前期患者血清NT-Pro BNP水平的变化
IF 2.2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-04-01 DOI: 10.2147/IBPC.S360584
Thanh Xuan Nguyen, Van Tri Nguyen, Hong Ngoc Nguyen-Phan, Bui Bao Hoang
Objective This study aims to determine the serum levels of NT-proBNP in women with preeclampsia with and without severe signs and to evaluate the cardiovascular risks in these two groups of participants. Methods A descriptive cross-sectional study was conducted on 52 women with preeclampsia in the Department of Gynecology and Obstetrics – Hue Central Hospital, from August 2019 to September 2020. Results In preeclampsia women, the rate of hypertension in stage 3, stage 2, and stage 1 were 46.1%, 32.7%, and 21.2%, respectively. The average Sokolow-Lyon index in the preeclampsia group with and without severe signs was 22.25 ± 7.38mm, 20.16 ± 5.54mm, respectively. The average left ventricular mass index in the group of preeclampsia patients without and with severe signs was 92.27 ± 14.56g/m2 and 120.68 ± 16.47g/m2, respectively. The average ejection fraction in the group of preeclampsia patients without severe signs and with severe signs was 65.11 ± 3.45%, 56.21 ± 7.12%, correspondingly. In contrast, the difference between the two groups was statistically significant with p < 0.05. The plasma NT-proBNP level in the preeclampsia group without severe signs was 349.12 ± 93.51pg/mL, whereas the concentration in the preeclampsia group with severe signs was 725.32 ± 290.46pg/mL (p < 0.05). Conclusion The NT-proBNP level was statistically significantly increased in the patients with preeclampsia. Analyzing and comparing the figures and changes found in two groups of PE patients, with and without severe signs, we suggest that women diagnosed with PE with severe signs have a higher risk of developing cardiovascular problems forthwith and henceforth.
目的本研究旨在测定先兆子痫伴和不伴严重症状妇女的血清NT-proBNP水平,并评估这两组参与者的心血管风险。方法2019年8月至2020年9月,对顺化市中心医院妇产科52名先兆子痫妇女进行描述性横断面研究。结果子痫前期妇女3期、2期和1期的高血压发生率分别为46.1%、32.7%和21.2%。先兆子痫伴和不伴严重体征组的平均Sokolow-Lyon指数分别为22.25±7.38mm和20.16±5.54mm。先兆子痫无症状组和有严重症状组的平均左心室质量指数分别为92.27±14.56g/m2和120.68±16.47g/m2。先兆子痫无严重体征组和有严重体征组的平均射血分数分别为65.11±3.45%、56.21±7.12%。相反,两组之间的差异具有统计学意义,p<0.05。无先兆子痫组血浆NT-proBNP水平为349.12±93.51pg/mL,有先兆子痫组为725.32±290.46pg/mL(p<0.05)。通过分析和比较两组PE患者(有严重体征和无严重体征)的数据和变化,我们认为,被诊断为PE伴严重体征的女性立即和以后出现心血管问题的风险更高。
{"title":"Serum Levels of NT-Pro BNP in Patients with Preeclampsia","authors":"Thanh Xuan Nguyen, Van Tri Nguyen, Hong Ngoc Nguyen-Phan, Bui Bao Hoang","doi":"10.2147/IBPC.S360584","DOIUrl":"https://doi.org/10.2147/IBPC.S360584","url":null,"abstract":"Objective This study aims to determine the serum levels of NT-proBNP in women with preeclampsia with and without severe signs and to evaluate the cardiovascular risks in these two groups of participants. Methods A descriptive cross-sectional study was conducted on 52 women with preeclampsia in the Department of Gynecology and Obstetrics – Hue Central Hospital, from August 2019 to September 2020. Results In preeclampsia women, the rate of hypertension in stage 3, stage 2, and stage 1 were 46.1%, 32.7%, and 21.2%, respectively. The average Sokolow-Lyon index in the preeclampsia group with and without severe signs was 22.25 ± 7.38mm, 20.16 ± 5.54mm, respectively. The average left ventricular mass index in the group of preeclampsia patients without and with severe signs was 92.27 ± 14.56g/m2 and 120.68 ± 16.47g/m2, respectively. The average ejection fraction in the group of preeclampsia patients without severe signs and with severe signs was 65.11 ± 3.45%, 56.21 ± 7.12%, correspondingly. In contrast, the difference between the two groups was statistically significant with p < 0.05. The plasma NT-proBNP level in the preeclampsia group without severe signs was 349.12 ± 93.51pg/mL, whereas the concentration in the preeclampsia group with severe signs was 725.32 ± 290.46pg/mL (p < 0.05). Conclusion The NT-proBNP level was statistically significantly increased in the patients with preeclampsia. Analyzing and comparing the figures and changes found in two groups of PE patients, with and without severe signs, we suggest that women diagnosed with PE with severe signs have a higher risk of developing cardiovascular problems forthwith and henceforth.","PeriodicalId":45299,"journal":{"name":"Integrated Blood Pressure Control","volume":"15 1","pages":"43 - 51"},"PeriodicalIF":2.2,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42859037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Perioperative Hypertension Etiologies in Patients Undergoing Noncardiac Surgery in University Health Network Hospitals–Canada from 2015–2020 2015-2020年加拿大大学健康网络医院接受非心脏手术患者围手术期高血压病因
IF 2.2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-03-01 DOI: 10.2147/IBPC.S347395
S. Mohseni, Sahar Behnam-Roudsari, Mohammad Tarbiat, Pouyan Shaker, Seyedmohammadshahab Shivaie, Mohammad Ali Shafiee
Introduction Perioperative hypertension, defined as increased blood pressure around the surgery, is a known risk factor for perioperative complications, including cardiovascular events. Identifying reasons associated with hypertension in each period is of great help in preventing and better managing perioperative hypertension. Objective The aim of the study was to explore common etiologies of hypertension during the perioperative period (pre, intra, and post-operation) in patients who underwent noncardiac surgeries in University Health Network (UHN) hospitals, Canada, from 2015 to 2020. Patients and Methods We retrospectively analyzed the medical records of 174 patients undergoing noncardiac surgeries who experienced perioperative hypertension. We assessed the prevalence of 10 reasons for perioperative hypertension as a whole and also each period separately according to the physicians’ notes in patients’ medical records. Two-way measurements ANOVA was used to determine the change of mean hypertension among patients for specific etiology. Results The common etiologies of perioperative hypertension were poorly controlled hypertension (21.8%), excessive fluid therapy (19.5%), excessive vasopressor (18.4%), and medication withdrawal (13.7%). Regarding each period separately, the most common reasons were poorly controlled hypertension for pre (42.9%) and intraoperative period (22.7%) and fluid overload for the postoperative period (20.1%). Poor control of hypertension showed both within-subject statistical significance for systolic and between-subject statistical significance for diastolic blood pressure. Conclusion Poorly controlled hypertension is the most significant etiology of perioperative hypertension in patients undergoing noncardiac surgeries. Apart from poorly controlled hypertension, as a patient-related factor, iatrogenic factors such as excessive vasopressor therapy, aggressive fluid replacement and poor management of antihypertensive medications can also cause perioperative hypertension.
引言围手术期高血压,定义为手术前后血压升高,是围手术期并发症(包括心血管事件)的已知风险因素。识别每个时期与高血压相关的原因对预防和更好地管理围手术期高血压有很大帮助。目的探讨2015年至2020年在加拿大大学健康网络(UHN)医院接受非心脏手术的患者围手术期(术前、术中和术后)高血压的常见病因。患者和方法我们回顾性分析174例非心脏手术患者围手术期高血压的病历。根据医生在患者病历中的记录,我们评估了围手术期高血压的10个原因的患病率,并分别评估了每个时期的患病率。双向测量方差分析用于确定特定病因患者平均高血压的变化。结果围手术期高血压的常见病因为高血压控制不良(21.8%)、补液过量(19.5%)、血管升压药过量(18.4%)和停药(13.7%),最常见的原因是术前(42.9%)和术中(22.7%)高血压控制不佳,术后(20.1%)液体超负荷。高血压控制不佳表现出收缩压在受试者内的统计学意义和舒张压在受检者间的统计学意义。结论高血压控制不良是非心脏手术患者围手术期高血压最重要的病因。除了高血压控制不佳外,作为一种与患者相关的因素,医源性因素,如过度的血管升压药治疗、积极的补液和降压药物管理不善,也会导致围手术期高血压。
{"title":"Perioperative Hypertension Etiologies in Patients Undergoing Noncardiac Surgery in University Health Network Hospitals–Canada from 2015–2020","authors":"S. Mohseni, Sahar Behnam-Roudsari, Mohammad Tarbiat, Pouyan Shaker, Seyedmohammadshahab Shivaie, Mohammad Ali Shafiee","doi":"10.2147/IBPC.S347395","DOIUrl":"https://doi.org/10.2147/IBPC.S347395","url":null,"abstract":"Introduction Perioperative hypertension, defined as increased blood pressure around the surgery, is a known risk factor for perioperative complications, including cardiovascular events. Identifying reasons associated with hypertension in each period is of great help in preventing and better managing perioperative hypertension. Objective The aim of the study was to explore common etiologies of hypertension during the perioperative period (pre, intra, and post-operation) in patients who underwent noncardiac surgeries in University Health Network (UHN) hospitals, Canada, from 2015 to 2020. Patients and Methods We retrospectively analyzed the medical records of 174 patients undergoing noncardiac surgeries who experienced perioperative hypertension. We assessed the prevalence of 10 reasons for perioperative hypertension as a whole and also each period separately according to the physicians’ notes in patients’ medical records. Two-way measurements ANOVA was used to determine the change of mean hypertension among patients for specific etiology. Results The common etiologies of perioperative hypertension were poorly controlled hypertension (21.8%), excessive fluid therapy (19.5%), excessive vasopressor (18.4%), and medication withdrawal (13.7%). Regarding each period separately, the most common reasons were poorly controlled hypertension for pre (42.9%) and intraoperative period (22.7%) and fluid overload for the postoperative period (20.1%). Poor control of hypertension showed both within-subject statistical significance for systolic and between-subject statistical significance for diastolic blood pressure. Conclusion Poorly controlled hypertension is the most significant etiology of perioperative hypertension in patients undergoing noncardiac surgeries. Apart from poorly controlled hypertension, as a patient-related factor, iatrogenic factors such as excessive vasopressor therapy, aggressive fluid replacement and poor management of antihypertensive medications can also cause perioperative hypertension.","PeriodicalId":45299,"journal":{"name":"Integrated Blood Pressure Control","volume":"15 1","pages":"23 - 32"},"PeriodicalIF":2.2,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41449765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study 与相同的多药治疗相比,单药联合治疗对高血压、血脂异常和心血管二级预防的影响:start研究
IF 2.2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-02-01 DOI: 10.2147/IBPC.S336324
T. Wilke, B. Weisser, H. Predel, R. Schmieder, S. Wassmann, A. Gillessen, J. Blettenberg, U. Maywald, O. Randerath, S. Mueller, M. Böhm
Aim Current guidelines for the treatment of arterial hypertension (AH) or cardiovascular (CV) prevention recommend combination drug treatments with single pill combinations (SPC) to improve adherence to treatment. We aimed to assess whether the SPC concept is clinically superior to multi pill combination (MPC) with identical drugs. Methods and Results In an explorative study, we analyzed anonymized claims data sets of patients treated with CV drugs for hypertension and/or CV disorders who were insured by the German AOK PLUS statutory health fund covering 01/07/2012-30/06/2018. Patients at age ≥18 years who received either a SPC or MPC with identical drugs were followed for up to one year. A one to one propensity score matching (PSM) was applied within patient groups who started identical drug combinations, and results were reported as incidence rate ratios (IRRs) as well as hazard ratios (HRs). After PSM, data from 59,336 patients were analyzed. In 30 out of 56 IRR analyses, superiority of SPC over MPC was shown. In 5 out of 7 comparisons, the HR for the composite outcome of all-cause death and all-cause hospitalizations was in favor of the SPC regimen (SPC versus MPC): valsartan/amlodipine: HR=0.87 (95% CI: 0.84–0.91, p ≤ 0.001); candesartan/amlodipine: 0.77 (95% CI: 0.65–0.90, p = 0.001); valsartan/amlodipine/hydrochlorothiazide: HR=0.68 (95% CI: 0.61–0.74, p ≤ 0.001); ramipril/amlodipine: HR=0.80 (95% CI: 0.77–0.83, p ≤ 0.001); acetylsalicylic acid (ASA)/atorvastatin/ramipril: HR=0.64 (95% CI: 0.47–0.88, p = 0.005). Conclusion SPC regimens are associated with a lower incidence of CV events and lower all-cause mortality in clinical practice. SPC regimens should generally be preferred to improve patient’s prognosis.
目的目前的动脉高压(AH)或心血管(CV)预防治疗指南建议采用单药联合用药(SPC)来提高治疗依从性。我们旨在评估SPC概念在临床上是否优于具有相同药物的多药丸组合(MPC)。方法和结果在一项探索性研究中,我们分析了接受CV药物治疗的高血压和/或CV障碍患者的匿名索赔数据集,这些患者由德国AOK PLUS法定健康基金承保,涵盖2012年7月1日至2018年6月30日。年龄≥18岁的患者接受SPC或MPC治疗,并使用相同的药物,随访长达一年。在开始相同药物组合的患者组中应用一对一倾向评分匹配(PSM),结果报告为发病率比(IRRs)和危险比(HR)。PSM后,对59336名患者的数据进行了分析。在56次内部收益率分析中,有30次表明SPC优于MPC。在7项比较中的5项中,全因死亡和全因住院的复合结果的HR有利于SPC方案(SPC与MPC):缬沙坦/氨氯地平:HR=0.87(95%CI:0.84–0.91,p≤0.001);坎地沙坦/氨氯地平:0.77(95%CI:0.65-0.90,p=0.001);缬沙坦/氨氯地平/氢氯噻嗪:HR=0.68(95%CI:0.61-0.74,p≤0.001);雷米普利/氨氯地平:HR=0.80(95%CI:0.77–0.83,p≤0.001);乙酰水杨酸(ASA)/阿托伐他汀/雷米普利:HR=0.64(95%CI:0.47–0.88,p=0.005)。结论SPC方案在临床实践中可降低心血管事件的发生率和全因死亡率。SPC方案通常应优先用于改善患者的预后。
{"title":"Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study","authors":"T. Wilke, B. Weisser, H. Predel, R. Schmieder, S. Wassmann, A. Gillessen, J. Blettenberg, U. Maywald, O. Randerath, S. Mueller, M. Böhm","doi":"10.2147/IBPC.S336324","DOIUrl":"https://doi.org/10.2147/IBPC.S336324","url":null,"abstract":"Aim Current guidelines for the treatment of arterial hypertension (AH) or cardiovascular (CV) prevention recommend combination drug treatments with single pill combinations (SPC) to improve adherence to treatment. We aimed to assess whether the SPC concept is clinically superior to multi pill combination (MPC) with identical drugs. Methods and Results In an explorative study, we analyzed anonymized claims data sets of patients treated with CV drugs for hypertension and/or CV disorders who were insured by the German AOK PLUS statutory health fund covering 01/07/2012-30/06/2018. Patients at age ≥18 years who received either a SPC or MPC with identical drugs were followed for up to one year. A one to one propensity score matching (PSM) was applied within patient groups who started identical drug combinations, and results were reported as incidence rate ratios (IRRs) as well as hazard ratios (HRs). After PSM, data from 59,336 patients were analyzed. In 30 out of 56 IRR analyses, superiority of SPC over MPC was shown. In 5 out of 7 comparisons, the HR for the composite outcome of all-cause death and all-cause hospitalizations was in favor of the SPC regimen (SPC versus MPC): valsartan/amlodipine: HR=0.87 (95% CI: 0.84–0.91, p ≤ 0.001); candesartan/amlodipine: 0.77 (95% CI: 0.65–0.90, p = 0.001); valsartan/amlodipine/hydrochlorothiazide: HR=0.68 (95% CI: 0.61–0.74, p ≤ 0.001); ramipril/amlodipine: HR=0.80 (95% CI: 0.77–0.83, p ≤ 0.001); acetylsalicylic acid (ASA)/atorvastatin/ramipril: HR=0.64 (95% CI: 0.47–0.88, p = 0.005). Conclusion SPC regimens are associated with a lower incidence of CV events and lower all-cause mortality in clinical practice. SPC regimens should generally be preferred to improve patient’s prognosis.","PeriodicalId":45299,"journal":{"name":"Integrated Blood Pressure Control","volume":"15 1","pages":"11 - 21"},"PeriodicalIF":2.2,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41526116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Treatment Outcome and Associated Factors Among Patients Admitted with Hypertensive Crisis in Public Hospitals at Harar Town, Eastern Ethiopia: A Cross-Sectional Study. 埃塞俄比亚东部哈拉尔镇公立医院收治的高血压危象患者的治疗结果及相关因素:一项横断面研究
IF 2.2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2022-01-01 DOI: 10.2147/IBPC.S386461
Nahom Samuel, Shambel Nigussie, Abera Jambo, Mesay Dechasa, Fekade Demeke, Abduro Godana, Abdi Birhanu, Tigist Gashaw, Assefa Agegnehu Teshome, Amas Siraj

Background: Hypertensive crisis is a significant global health issue that raises the costs to healthcare systems and requires specific attention to improve clinical outcome. There is scarce information on hypertensive crisis cases treatment outcome in the study setting.

Objective: This study aimed to assess treatment outcome and associated factors among patients admitted with hypertensive crisis at Public Hospitals in Harar Town, Eastern Ethiopia.

Methods: A cross-sectional study was conducted among 369 hypertensive crisis patients who had been admitted to the emergency department of Hiwot Fana Comprehensive Specialized Hospital and Jugol General Hospital from May 1, 2017, to May 1, 2022. All hypertensive crisis patients who fulfilled the inclusion criteria were included. The data were extracted from medical records using a data abstraction format. The collected data were analyzed using Statistical Package for Social Sciences version 22. Binary logistics regression model using bivariate and multivariable analysis with 95% confidence intervals and P-values were used to determine the association between variables.

Results: The medical records of 369 patients in total were reviewed. Of these, the medical records of 363 patients contained all the necessary information and were used in the study. More than half of the patients (238; 65.6%) were males. Among 363 patients admitted with hypertensive crisis, 98 (27.0%, 95% Confidence Interval (CI):22.5%-31.9%) of them had poor treatment outcome of hypertensive crisis. Being female (Adjusted Odds Ratio (AOR)=3.4; 95% CI=1.7-7.9), residing in rural areas (AOR=2.4; 95% CI=2.7-5.1), taking captopril during admission (AOR=5.6; 95% CI=2.4-7.9), taking antihypertensive treatment before admission (AOR=0.5; 95% CI=0.2-0.9), and being non compliant to treatment (AOR=2.7; 95% CI=1.4-3.5) had statistically significant associations with poor treatment outcome of hypertensive crisis compared to their counterparts.

Conclusion: The magnitude of poor treatment outcome of hypertensive crisis was high. Sex, residence, non-compliance, and type of emergency drug administered during admission were substantially related with poor treatment outcome of hypertensive crisis. Health professionals should put great emphasis on emergency drugs administered during admission to achieve the desired outcome.

背景:高血压危像是一个重要的全球健康问题,它增加了医疗保健系统的成本,需要特别关注以改善临床结果。在研究背景下,关于高血压危象病例治疗结果的信息很少。目的:本研究旨在评估埃塞俄比亚东部哈拉尔镇公立医院收治的高血压危象患者的治疗结果和相关因素。方法:对2017年5月1日至2022年5月1日在希沃特法纳综合专科医院和居戈尔综合医院急诊科收治的369例高血压危重症患者进行横断面研究。所有符合纳入标准的高血压危重症患者均被纳入。使用数据抽象格式从医疗记录中提取数据。收集的数据使用Statistical Package for Social Sciences version 22进行分析。二元logistic回归模型采用双变量和多变量分析,95%置信区间和p值确定变量之间的相关性。结果:共查阅369例患者的病历。其中,363名患者的医疗记录包含了所有必要的信息,并被用于研究。超过一半的患者(238;65.6%)为男性。363例入院的高血压危象患者中,98例(27.0%,95%可信区间(CI):22.5% ~ 31.9%)高血压危象治疗效果较差。女性(调整优势比(AOR)=3.4;95% CI=1.7-7.9),居住在农村地区(AOR=2.4;95% CI=2.7-5.1),入院时服用卡托普利(AOR=5.6;95% CI=2.4-7.9),入院前已接受抗高血压治疗(AOR=0.5;95% CI=0.2-0.9),不适应治疗(AOR=2.7;95% CI=1.4-3.5)与高血压危象治疗结果差有统计学意义。结论:高血压危象治疗不良程度高。性别、居住地、不依从性和入院时使用的急诊药物类型与高血压危重症的不良治疗结果有实质性关系。卫生专业人员应高度重视在入院时使用的紧急药物,以达到预期的效果。
{"title":"Treatment Outcome and Associated Factors Among Patients Admitted with Hypertensive Crisis in Public Hospitals at Harar Town, Eastern Ethiopia: A Cross-Sectional Study.","authors":"Nahom Samuel,&nbsp;Shambel Nigussie,&nbsp;Abera Jambo,&nbsp;Mesay Dechasa,&nbsp;Fekade Demeke,&nbsp;Abduro Godana,&nbsp;Abdi Birhanu,&nbsp;Tigist Gashaw,&nbsp;Assefa Agegnehu Teshome,&nbsp;Amas Siraj","doi":"10.2147/IBPC.S386461","DOIUrl":"https://doi.org/10.2147/IBPC.S386461","url":null,"abstract":"<p><strong>Background: </strong>Hypertensive crisis is a significant global health issue that raises the costs to healthcare systems and requires specific attention to improve clinical outcome. There is scarce information on hypertensive crisis cases treatment outcome in the study setting.</p><p><strong>Objective: </strong>This study aimed to assess treatment outcome and associated factors among patients admitted with hypertensive crisis at Public Hospitals in Harar Town, Eastern Ethiopia.</p><p><strong>Methods: </strong>A cross-sectional study was conducted among 369 hypertensive crisis patients who had been admitted to the emergency department of Hiwot Fana Comprehensive Specialized Hospital and Jugol General Hospital from May 1, 2017, to May 1, 2022. All hypertensive crisis patients who fulfilled the inclusion criteria were included. The data were extracted from medical records using a data abstraction format. The collected data were analyzed using Statistical Package for Social Sciences version 22. Binary logistics regression model using bivariate and multivariable analysis with 95% confidence intervals and <i>P</i>-values were used to determine the association between variables.</p><p><strong>Results: </strong>The medical records of 369 patients in total were reviewed. Of these, the medical records of 363 patients contained all the necessary information and were used in the study. More than half of the patients (238; 65.6%) were males. Among 363 patients admitted with hypertensive crisis, 98 (27.0%, 95% Confidence Interval (CI):22.5%-31.9%) of them had poor treatment outcome of hypertensive crisis. Being female (Adjusted Odds Ratio (AOR)=3.4; 95% CI=1.7-7.9), residing in rural areas (AOR=2.4; 95% CI=2.7-5.1), taking captopril during admission (AOR=5.6; 95% CI=2.4-7.9), taking antihypertensive treatment before admission (AOR=0.5; 95% CI=0.2-0.9), and being non compliant to treatment (AOR=2.7; 95% CI=1.4-3.5) had statistically significant associations with poor treatment outcome of hypertensive crisis compared to their counterparts.</p><p><strong>Conclusion: </strong>The magnitude of poor treatment outcome of hypertensive crisis was high. Sex, residence, non-compliance, and type of emergency drug administered during admission were substantially related with poor treatment outcome of hypertensive crisis. Health professionals should put great emphasis on emergency drugs administered during admission to achieve the desired outcome.</p>","PeriodicalId":45299,"journal":{"name":"Integrated Blood Pressure Control","volume":"15 ","pages":"113-122"},"PeriodicalIF":2.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/10/43/ibpc-15-113.PMC9758999.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10402047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Diastolic Blood Pressure J-Curve in Hypertension Management: Links and Risk for Cardiovascular Disease. 高血压管理中的舒张压 J 曲线:心血管疾病的关联与风险。
IF 1.5 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2021-12-14 eCollection Date: 2021-01-01 DOI: 10.2147/IBPC.S286957
Brian Gaffney, Alan P Jacobsen, Abhishek W Pallippattu, Niall Leahy, John W McEvoy

Purpose of review: The treatment of hypertension has changed dramatically over the last century, with recent trials informing clinical guidelines that recommend aiming for lower blood pressure (BP) targets than ever before. However, a "J"- or "U-shaped curve" in the association between diastolic BP and cardiovascular events has been observed in epidemiological studies, suggesting that both high diastolic BPs and diastolic BPs below a certain nadir are associated with higher risk of cardiovascular disease (CVD) events. Despite the potential for confounding and reverse causation, this association may caution against overly intensive BP lowering in some hypertensive adults who also have a low baseline diastolic BP.

Recent findings: Recent post-hoc analyses of the landmark Systolic Blood Pressure Intervention Trial (SPRINT) appear to contradict these J-curve concerns, finding that the benefit of more intensive BP treatment did not differ based on baseline blood pressure. Similarly, sensitivity analyses of The Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) randomized controlled trial found that patients experienced similar benefits from an intensive BP goal, regardless of whether their diastolic BP was above or below 60 mm Hg. Finally, several Mendelian randomization analyses, which are less susceptible to confounding and reverse causation, demonstrated a clear linear relationship between diastolic BP and cardiovascular events. These studies indicate that a potential reduction in CVD risk is possible, irrespective of baseline diastolic BP values.

Summary: Sufficient recent evidence indicates that low diastolic BP is not causal of worse cardiovascular outcomes but rather represents confounding or reverse causation. Therefore, while low diastolic BP can be considered a marker of CVD risk, this risk is not expected to increase with further BP lowering when necessary to control concomitant elevations of systolic BP. Indeed, BP reduction in this setting appears beneficial.

综述目的:高血压的治疗在上个世纪发生了巨大变化,最近的试验为临床指南提供了依据,指南建议将目标血压(BP)定得比以往任何时候都低。然而,在流行病学研究中观察到,舒张压与心血管事件之间的关系呈 "J "形或 "U "形曲线,表明舒张压过高和舒张压低于某一最低点都与心血管疾病(CVD)事件的风险较高有关。尽管存在混淆和反向因果关系的可能性,但这种关联可能提醒人们,对于一些舒张压基线也较低的高血压成人,不要过度强化降压治疗:最近对具有里程碑意义的收缩压干预试验(SPRINT)进行的事后分析似乎与这些 J 型曲线的担忧相矛盾,分析发现,根据基线血压的不同,强化降压治疗的益处也不尽相同。同样,"老年高血压患者血压干预策略"(STEP)随机对照试验的敏感性分析也发现,无论患者的舒张压是高于还是低于 60 毫米汞柱,都能从强化降压目标中获得类似的益处。最后,几项不易受混杂因素和反向因果关系影响的孟德尔随机分析表明,舒张压与心血管事件之间存在明显的线性关系。这些研究表明,无论舒张压基线值如何,都有可能降低心血管疾病风险。小结:最近有足够的证据表明,舒张压过低并不是心血管疾病恶化的因果关系,而是混杂或反向因果关系。因此,尽管舒张压过低可被视为心血管疾病风险的一个标志,但在必要时进一步降低血压以控制同时出现的收缩压升高,预计这种风险不会增加。事实上,在这种情况下降低血压似乎是有益的。
{"title":"The Diastolic Blood Pressure J-Curve in Hypertension Management: Links and Risk for Cardiovascular Disease.","authors":"Brian Gaffney, Alan P Jacobsen, Abhishek W Pallippattu, Niall Leahy, John W McEvoy","doi":"10.2147/IBPC.S286957","DOIUrl":"10.2147/IBPC.S286957","url":null,"abstract":"<p><strong>Purpose of review: </strong>The treatment of hypertension has changed dramatically over the last century, with recent trials informing clinical guidelines that recommend aiming for lower blood pressure (BP) targets than ever before. However, a \"J\"- or \"U-shaped curve\" in the association between diastolic BP and cardiovascular events has been observed in epidemiological studies, suggesting that both high diastolic BPs and diastolic BPs below a certain nadir are associated with higher risk of cardiovascular disease (CVD) events. Despite the potential for confounding and reverse causation, this association may caution against overly intensive BP lowering in some hypertensive adults who also have a low baseline diastolic BP.</p><p><strong>Recent findings: </strong>Recent post-hoc analyses of the landmark Systolic Blood Pressure Intervention Trial (SPRINT) appear to contradict these J-curve concerns, finding that the benefit of more intensive BP treatment did not differ based on baseline blood pressure. Similarly, sensitivity analyses of The Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) randomized controlled trial found that patients experienced similar benefits from an intensive BP goal, regardless of whether their diastolic BP was above or below 60 mm Hg. Finally, several Mendelian randomization analyses, which are less susceptible to confounding and reverse causation, demonstrated a clear linear relationship between diastolic BP and cardiovascular events. These studies indicate that a potential reduction in CVD risk is possible, irrespective of baseline diastolic BP values.</p><p><strong>Summary: </strong>Sufficient recent evidence indicates that low diastolic BP is not causal of worse cardiovascular outcomes but rather represents confounding or reverse causation. Therefore, while low diastolic BP can be considered a marker of CVD risk, this risk is not expected to increase with further BP lowering when necessary to control concomitant elevations of systolic BP. Indeed, BP reduction in this setting appears beneficial.</p>","PeriodicalId":45299,"journal":{"name":"Integrated Blood Pressure Control","volume":"14 ","pages":"179-187"},"PeriodicalIF":1.5,"publicationDate":"2021-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ce/ed/ibpc-14-179.PMC8685549.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39748793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Qualitative Study on Barriers to Treatment and Control of Hypertension Among Patients at Dessie Referral Hospital, Northeast Ethiopia, Ethiopia: Healthcare Workers' Perspective. 关于埃塞俄比亚东北部 Dessie 转诊医院患者治疗和控制高血压障碍的定性研究:医护人员的观点。
IF 2.2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2021-12-03 eCollection Date: 2021-01-01 DOI: 10.2147/IBPC.S339773
Yeshewas Abaynew, Mohammed Hussien

Introduction: Hypertension is the leading cause of morbidity and mortality and accounts for 13% of all deaths and 7% of the disease burden in the world. Although the importance of controlling hypertension has been recognized for many years, the majority of patients with hypertension remain uncontrolled. Studies indicate a very low adherence to lifestyle modifications among patients in the study area. Hypertensive patients face set of problems associated with adherence to antihypertensive drugs and healthy lifestyle modifications.

Objective: The objective of the study was to explore barriers to hypertension treatment and control from healthcare workers' perspective and experiences at Dessie Referral Hospital, Ethiopia.

Methods: Seven healthcare workers actively involved in managing hypertensive individuals at Dessie Referral Hospital were recruited for the study. Participants were purposively selected from outpatient, inpatient, and pharmacy departments. The required data were collected by the principal investigator on exit interviews. An interview guide was developed by reviewing previous literature. Interviews were semi-structured, 8-20 minutes in duration, and designed to elicit healthcare workers'experiences and perceptions and conducted until data saturation was reached. All interviews were recorded, transcribed verbatim, and thematically analyzed. Each theme was supported by using the participants' quotes.

Results: Three themes emerged. The major barriers impacted patients' medication adherence and healthy lifestyle modifications were common use of diets during social settings, low level of awareness, lack of resources, misconceptions about hypertension, use of traditional medicines, inadequate physical activities, and high cost of drugs.

Conclusion: Patients' misconceptions about hypertension, common use of diets during festivals, and inadequate physical activities were factors associated with inadequate blood pressure control. Healthcare workers should better understand the problems that hypertensive patients' face, thus achieving better control.

导言:高血压是发病和死亡的主要原因,占全球死亡总数的 13%,占疾病负担的 7%。尽管控制高血压的重要性已被认识多年,但大多数高血压患者仍未得到控制。研究表明,研究地区的患者对生活方式调整的依从性非常低。高血压患者面临着一系列与坚持服用降压药和改变健康生活方式相关的问题:本研究旨在从埃塞俄比亚德西转诊医院医护人员的角度和经验出发,探讨高血压治疗和控制的障碍:研究招募了七名在德西转诊医院积极从事高血压患者管理工作的医护人员。研究人员从门诊部、住院部和药房有目的性地挑选出来。主要研究人员通过离职访谈收集所需数据。通过查阅以前的文献,制定了访谈指南。访谈采用半结构式,时间为 8-20 分钟,旨在了解医护人员的经验和看法,访谈进行到数据饱和为止。所有访谈都进行了录音、逐字记录和主题分析。每个主题都有参与者的引述作为支持:结果:出现了三个主题。影响患者坚持服药和改变健康生活方式的主要障碍包括:在社交场合普遍使用饮食、认知水平低、缺乏资源、对高血压的误解、使用传统药物、体育活动不足以及药物价格昂贵:结论:患者对高血压的误解、逢年过节时的饮食习惯和体育锻炼不足是导致血压控制不佳的相关因素。医护人员应更好地了解高血压患者面临的问题,从而更好地控制血压。
{"title":"A Qualitative Study on Barriers to Treatment and Control of Hypertension Among Patients at Dessie Referral Hospital, Northeast Ethiopia, Ethiopia: Healthcare Workers' Perspective.","authors":"Yeshewas Abaynew, Mohammed Hussien","doi":"10.2147/IBPC.S339773","DOIUrl":"10.2147/IBPC.S339773","url":null,"abstract":"<p><strong>Introduction: </strong>Hypertension is the leading cause of morbidity and mortality and accounts for 13% of all deaths and 7% of the disease burden in the world. Although the importance of controlling hypertension has been recognized for many years, the majority of patients with hypertension remain uncontrolled. Studies indicate a very low adherence to lifestyle modifications among patients in the study area. Hypertensive patients face set of problems associated with adherence to antihypertensive drugs and healthy lifestyle modifications.</p><p><strong>Objective: </strong>The objective of the study was to explore barriers to hypertension treatment and control from healthcare workers' perspective and experiences at Dessie Referral Hospital, Ethiopia.</p><p><strong>Methods: </strong>Seven healthcare workers actively involved in managing hypertensive individuals at Dessie Referral Hospital were recruited for the study. Participants were purposively selected from outpatient, inpatient, and pharmacy departments. The required data were collected by the principal investigator on exit interviews. An interview guide was developed by reviewing previous literature. Interviews were semi-structured, 8-20 minutes in duration, and designed to elicit healthcare workers'experiences and perceptions and conducted until data saturation was reached. All interviews were recorded, transcribed verbatim, and thematically analyzed. Each theme was supported by using the participants' quotes.</p><p><strong>Results: </strong>Three themes emerged. The major barriers impacted patients' medication adherence and healthy lifestyle modifications were common use of diets during social settings, low level of awareness, lack of resources, misconceptions about hypertension, use of traditional medicines, inadequate physical activities, and high cost of drugs.</p><p><strong>Conclusion: </strong>Patients' misconceptions about hypertension, common use of diets during festivals, and inadequate physical activities were factors associated with inadequate blood pressure control. Healthcare workers should better understand the problems that hypertensive patients' face, thus achieving better control.</p>","PeriodicalId":45299,"journal":{"name":"Integrated Blood Pressure Control","volume":"14 ","pages":"173-178"},"PeriodicalIF":2.2,"publicationDate":"2021-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/87/bf/ibpc-14-173.PMC8650830.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39711061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determinants of Preeclampsia Among Pregnant Women in Chiro Referral Hospital, Oromia Regional State, Ethiopia: Unmatched Case-Control Study. 埃塞俄比亚奥罗米亚州Chiro转诊医院孕妇先兆子痫的决定因素:无与伦比的病例对照研究。
IF 2.2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2021-12-01 eCollection Date: 2021-01-01 DOI: 10.2147/IBPC.S336651
Fikre Hambamo Katore, Abenet Menene Gurara, Teresa Kisi Beyen

Background: Preeclampsia causes striking maternal, fetal, and neonatal mortality and morbidity both in developed and developing countries. However, evidence of risk factors of preeclampsia is limited in the study area.

Objective: To identify determinants of preeclampsia among pregnant women attending antenatal care services in Ciro Referral Hospital, Ethiopia, 2020.

Methods: A facility-based unmatched case-control study was conducted from July 1 to July 30, 2020, in Chiro Referral Hospital on a sample size of 306 (ie, 76 cases and 230 controls; with a 1:3 ratio). Data were coded and entered into Epi Info version 7 and then exported to SPSS version 21 for analysis. The odds ratio was calculated with 95% confidence intervals to show the strength of association and p-value<0.05 was used to declare statistical significance.

Results: A total of 302 (75 cases and 227 controls) pregnant mothers were interviewed with a response rate of 98.7%. Being in the age group ≥35 years (AOR=4.00; 95% CI=1.25-12.80), rural residence (AOR=3.30; 95% CI=1.50-7.26), having a family history of hypertension (AOR=3.25; 95% CI=1.36-7.73), and being primigravida (AOR=3.71; 95% CI=1.49-9.22) were identified as risk factors for preeclampsia. However, consuming fruits more than 2-4 times per a week in their diet (AOR=0.38; 95% CI=0.15-0.98) was a protective predictor of preeclampsia.

Conclusion: Maternal age, residence, family history of hypertension, gravida, and frequency of fruit consumption were identified determinants of preeclampsia. Thus, healthcare providers should give emphasis for pregnant mothers in the older age category, primigravida, those who have a history of a family with hypertension, and those from a rural residence to diagnose the diseases as early as possible. Additionally, advising pregnant mothers attending antenatal care to consume fruits as early as possible in their daily diet reduces the risk of preeclampsia.

背景:先兆子痫在发达国家和发展中国家都会导致惊人的孕产妇、胎儿和新生儿死亡率和发病率。然而,先兆子痫危险因素的证据在研究领域是有限的。目的:确定2020年在埃塞俄比亚西罗转诊医院接受产前护理的孕妇中先兆子痫的决定因素。方法:于2020年7月1日至7月30日在西罗转介医院进行了一项基于设施的非匹配病例对照研究,样本量为306(即76例病例和230例对照;比例为1:3)。数据被编码并输入Epi Info版本7,然后导出到SPSS版本21进行分析。以95%置信区间计算比值比,以显示关联强度和p值。结果:共采访了302名孕妇(75例和227名对照),回答率为98.7%。年龄组≥35岁(AOR=4.00;95%CI=1.25-12.80)、农村(AOR=3.30;95%CI=1.50-7.26),有高血压家族史(AOR=3.25;95%CI=1.36-7.73)和初产妇(AOR=3.71;95%CI=1.49-9.22)被确定为先兆子痫的危险因素。然而,在饮食中每周食用水果2-4次以上(AOR=0.38;95%CI=0.15-0.98)是先兆子痫的保护性预测因素。结论:母亲年龄、居住地、高血压家族史、妊娠期和食用水果的频率是先兆子痫的决定因素。因此,医疗保健提供者应重视老年孕妇、初产妇、有高血压家族史的孕妇和来自农村的孕妇,以便尽早诊断疾病。此外,建议参加产前护理的孕妇在日常饮食中尽早食用水果可以降低先兆子痫的风险。
{"title":"Determinants of Preeclampsia Among Pregnant Women in Chiro Referral Hospital, Oromia Regional State, Ethiopia: Unmatched Case-Control Study.","authors":"Fikre Hambamo Katore,&nbsp;Abenet Menene Gurara,&nbsp;Teresa Kisi Beyen","doi":"10.2147/IBPC.S336651","DOIUrl":"10.2147/IBPC.S336651","url":null,"abstract":"<p><strong>Background: </strong>Preeclampsia causes striking maternal, fetal, and neonatal mortality and morbidity both in developed and developing countries. However, evidence of risk factors of preeclampsia is limited in the study area.</p><p><strong>Objective: </strong>To identify determinants of preeclampsia among pregnant women attending antenatal care services in Ciro Referral Hospital, Ethiopia, 2020.</p><p><strong>Methods: </strong>A facility-based unmatched case-control study was conducted from July 1 to July 30, 2020, in Chiro Referral Hospital on a sample size of 306 (ie, 76 cases and 230 controls; with a 1:3 ratio). Data were coded and entered into Epi Info version 7 and then exported to SPSS version 21 for analysis. The odds ratio was calculated with 95% confidence intervals to show the strength of association and <i>p</i>-value<0.05 was used to declare statistical significance.</p><p><strong>Results: </strong>A total of 302 (75 cases and 227 controls) pregnant mothers were interviewed with a response rate of 98.7%. Being in the age group ≥35 years (AOR=4.00; 95% CI=1.25-12.80), rural residence (AOR=3.30; 95% CI=1.50-7.26), having a family history of hypertension (AOR=3.25; 95% CI=1.36-7.73), and being primigravida (AOR=3.71; 95% CI=1.49-9.22) were identified as risk factors for preeclampsia. However, consuming fruits more than 2-4 times per a week in their diet (AOR=0.38; 95% CI=0.15-0.98) was a protective predictor of preeclampsia.</p><p><strong>Conclusion: </strong>Maternal age, residence, family history of hypertension, gravida, and frequency of fruit consumption were identified determinants of preeclampsia. Thus, healthcare providers should give emphasis for pregnant mothers in the older age category, primigravida, those who have a history of a family with hypertension, and those from a rural residence to diagnose the diseases as early as possible. Additionally, advising pregnant mothers attending antenatal care to consume fruits as early as possible in their daily diet reduces the risk of preeclampsia.</p>","PeriodicalId":45299,"journal":{"name":"Integrated Blood Pressure Control","volume":"14 ","pages":"163-172"},"PeriodicalIF":2.2,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/db/d1/ibpc-14-163.PMC8646106.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39816644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Which anthropometric and metabolic index is superior in hypertension prediction among overweight/obese adults? 哪种人体测量和代谢指标在超重/肥胖成人高血压预测中更优越?
IF 2.2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2021-11-08 eCollection Date: 2021-01-01 DOI: 10.2147/IBPC.S340664
Maryam Abolhasani, Nastaran Maghbouli, Shahrokh Karbalai Saleh, Ziba Aghsaeifar, Faeze Sazgara, Maryam Tahmasebi, Haleh Ashraf, Jemal Haidar Ali

Background: Although the effectiveness of some combined anthropometric and metabolic scores were evaluated in hypertension prediction, none of them had addressed their accuracy in association with overweight/obese populations. This study examined the accuracy of several anthropometric parameters in this regard and compared the novel indices to the ancient ones.

Methods: Through a cross-sectional study, 5115 patients have been evaluated at the weight loss clinic. Data on demographic information, anthropometric indices, and biochemical measurements were assembled into a checklist. Multivariable regression modeling and the area under the receiver-operating characteristic (ROC) were analyzed using SPSS version 20. To find new combined scores, SEM (structural equation modeling) analysis was also adopted. P-values < 0.05 were considered statistically significant.

Results: Considering ancient indices, WHtR (waist-to-height ratio) showed a sufficient area under the curve in predicting hypertension among both genders concomitant with WC (waist circumference) in men, and BRI (body roundness index) in women as highest AUC. The highest odds ratio (OR) for the presence of hypertension, based on the age-adjusted model, was BRI in females (OR, 3.335; 95% confidence interval [CI], 1.58-7.28) and WC in males (OR, 13.478; 95% CI: 1.99-45.02). The combined scores were not superior to the single ones.

Conclusion: The most powerful association between hypertension and sufficient discrimination ability of normotensives from hypertensive patients was detected for BRI in women and WC among men. However, neither the BSI and BAI nor FMI and FFMI showed superiority to WC or WHtR in predicting the presence of hypertension.

背景:虽然一些人体测量和代谢综合评分在高血压预测中的有效性得到了评估,但它们都没有解决其与超重/肥胖人群相关的准确性。本研究检验了这方面几个人体测量参数的准确性,并将新指标与古代指标进行了比较。方法:通过一项横断面研究,对5115例减肥门诊患者进行了评估。人口统计信息、人体测量指数和生化测量数据被汇编成一个核对表。采用SPSS version 20对多变量回归模型和受试者工作特征下面积(ROC)进行分析。为了寻找新的组合分数,还采用了结构方程模型(SEM)分析。p值< 0.05认为有统计学意义。结果:考虑到古老的指标,WHtR(腰高比)与男性WC(腰围)的曲线下面积足够预测男女高血压,女性BRI(身体圆度指数)的AUC最高。基于年龄校正模型,高血压存在的最高优势比(OR)是女性BRI (OR, 3.335;95%可信区间[CI], 1.58-7.28)和男性WC (OR, 13.478;95% ci: 1.99-45.02)。综合得分不优于单项得分。结论:在高血压患者中,女性患者的BRI和男性患者的WC与血压正常者的充分识别能力之间的相关性最强。然而,BSI和BAI、FMI和FFMI在预测高血压存在方面都没有WC或WHtR的优势。
{"title":"Which anthropometric and metabolic index is superior in hypertension prediction among overweight/obese adults?","authors":"Maryam Abolhasani,&nbsp;Nastaran Maghbouli,&nbsp;Shahrokh Karbalai Saleh,&nbsp;Ziba Aghsaeifar,&nbsp;Faeze Sazgara,&nbsp;Maryam Tahmasebi,&nbsp;Haleh Ashraf,&nbsp;Jemal Haidar Ali","doi":"10.2147/IBPC.S340664","DOIUrl":"https://doi.org/10.2147/IBPC.S340664","url":null,"abstract":"<p><strong>Background: </strong>Although the effectiveness of some combined anthropometric and metabolic scores were evaluated in hypertension prediction, none of them had addressed their accuracy in association with overweight/obese populations. This study examined the accuracy of several anthropometric parameters in this regard and compared the novel indices to the ancient ones.</p><p><strong>Methods: </strong>Through a cross-sectional study, 5115 patients have been evaluated at the weight loss clinic. Data on demographic information, anthropometric indices, and biochemical measurements were assembled into a checklist. Multivariable regression modeling and the area under the receiver-operating characteristic (ROC) were analyzed using SPSS version 20. To find new combined scores, SEM (structural equation modeling) analysis was also adopted. P-values < 0.05 were considered statistically significant.</p><p><strong>Results: </strong>Considering ancient indices, WHtR (waist-to-height ratio) showed a sufficient area under the curve in predicting hypertension among both genders concomitant with WC (waist circumference) in men, and BRI (body roundness index) in women as highest AUC. The highest odds ratio (OR) for the presence of hypertension, based on the age-adjusted model, was BRI in females (OR, 3.335; 95% confidence interval [CI], 1.58-7.28) and WC in males (OR, 13.478; 95% CI: 1.99-45.02). The combined scores were not superior to the single ones.</p><p><strong>Conclusion: </strong>The most powerful association between hypertension and sufficient discrimination ability of normotensives from hypertensive patients was detected for BRI in women and WC among men. However, neither the BSI and BAI nor FMI and FFMI showed superiority to WC or WHtR in predicting the presence of hypertension.</p>","PeriodicalId":45299,"journal":{"name":"Integrated Blood Pressure Control","volume":"14 ","pages":"153-161"},"PeriodicalIF":2.2,"publicationDate":"2021-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/41/a7/ibpc-14-153.PMC8593692.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39637903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Insights into the Mechanisms of Fetal Growth Restriction-Induced Programming of Hypertension. 透视胎儿生长受限诱发高血压的机制
IF 2.2 Q3 PERIPHERAL VASCULAR DISEASE Pub Date : 2021-10-09 eCollection Date: 2021-01-01 DOI: 10.2147/IBPC.S312868
Benjamin Bhunu, Isabel Riccio, Suttira Intapad

In recent decades, both clinical and animal studies have shown that fetal growth restriction (FGR), caused by exposure to adverse uterine environments, is a risk factor for hypertension as well as for a variety of adult diseases. This observation has shaped and informed the now widely accepted theory of developmental origins of health and disease (DOHaD). There is a plethora of evidence supporting the association of FGR with increased risk of adult hypertension; however, the underlying mechanisms responsible for this correlation remain unclear. This review aims to explain the current advances in the field of fetal programming of hypertension and a brief narration of the underlying mechanisms that may link FGR to increased risk of adult hypertension. We explain the theory of DOHaD and then provide evidence from both clinical and basic science research which support the theory of fetal programming of adult hypertension. In addition, we have explored the underlying mechanisms that may link FGR to an increased risk of adult hypertension. These mechanisms include epigenetic changes, metabolic disorders, vascular dysfunction, neurohormonal impairment, and alterations in renal physiology and function. We further describe sex differences seen in the developmental origins of hypertension and provide insights into the opportunities and challenges present in this field.

近几十年来,临床研究和动物实验都表明,胎儿生长受限(FGR)是由不良子宫环境引起的,是高血压和多种成人疾病的危险因素。这一观察结果形成了现在广为接受的健康和疾病的发育起源理论(DOHaD),并为其提供了依据。有大量证据支持胎儿畸形与成人高血压风险增加有关;然而,造成这种相关性的潜在机制仍不清楚。本综述旨在解释高血压胎儿编程领域的最新进展,并简要叙述可能将 FGR 与成人高血压风险增加联系起来的内在机制。我们解释了DOHaD理论,然后提供了临床和基础科学研究中支持胎儿编程成人高血压理论的证据。此外,我们还探讨了可能将 FGR 与成人高血压风险增加联系起来的潜在机制。这些机制包括表观遗传学变化、代谢紊乱、血管功能障碍、神经荷尔蒙损伤以及肾脏生理和功能的改变。我们进一步描述了高血压发育起源中的性别差异,并深入探讨了这一领域的机遇和挑战。
{"title":"Insights into the Mechanisms of Fetal Growth Restriction-Induced Programming of Hypertension.","authors":"Benjamin Bhunu, Isabel Riccio, Suttira Intapad","doi":"10.2147/IBPC.S312868","DOIUrl":"10.2147/IBPC.S312868","url":null,"abstract":"<p><p>In recent decades, both clinical and animal studies have shown that fetal growth restriction (FGR), caused by exposure to adverse uterine environments, is a risk factor for hypertension as well as for a variety of adult diseases. This observation has shaped and informed the now widely accepted theory of developmental origins of health and disease (DOHaD). There is a plethora of evidence supporting the association of FGR with increased risk of adult hypertension; however, the underlying mechanisms responsible for this correlation remain unclear. This review aims to explain the current advances in the field of fetal programming of hypertension and a brief narration of the underlying mechanisms that may link FGR to increased risk of adult hypertension. We explain the theory of DOHaD and then provide evidence from both clinical and basic science research which support the theory of fetal programming of adult hypertension. In addition, we have explored the underlying mechanisms that may link FGR to an increased risk of adult hypertension. These mechanisms include epigenetic changes, metabolic disorders, vascular dysfunction, neurohormonal impairment, and alterations in renal physiology and function. We further describe sex differences seen in the developmental origins of hypertension and provide insights into the opportunities and challenges present in this field.</p>","PeriodicalId":45299,"journal":{"name":"Integrated Blood Pressure Control","volume":"14 ","pages":"141-152"},"PeriodicalIF":2.2,"publicationDate":"2021-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e1/eb/ibpc-14-141.PMC8517636.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39541032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Integrated Blood Pressure Control
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1